Labauge Pierre, Horzinski Laetitia, Ayrignac Xavier, Blanc Pierre, Vukusic Sandra, Rodriguez Diana, Mauguiere Francois, Peter Laure, Goizet Cyril, Bouhour Francoise, Denier Christian, Confavreux Christian, Obadia Michael, Blanc Frederic, de Sèze Jérome, Fogli Anne, Boespflug-Tanguy Odile
CHU Nîmes, Service de neurologie, Hôpital Caremeau, place du Professeur-Debré, 30029 Nîmes cedex 4, France.
Brain. 2009 Aug;132(Pt 8):2161-9. doi: 10.1093/brain/awp171.
Mutations in one of the five eukaryotic initiation factor 2B genes (EIF2B1-5) were first described in childhood ataxia with cerebral hypomyelination--vanishing white matter syndrome. The syndrome is characterized by (i) cerebellar and pyramidal signs in children aged 2-5 years; (ii) extensive cavitating leucoencephalopathy; and (iii) episodes of rapid deterioration following stress. Since then a broad clinical spectrum from congenital to adult-onset forms has been reported, leading to the concept of eIF2B-related disorders. Our aim was to describe clinical and brain magnetic resonance imaging characteristics, genetic findings and natural history of patients with adult-onset eIF2B-related disorders (after age 16). The inclusion criteria were based on the presence of eIF2B mutations and a disease onset after the age of 16 years. One patient with an asymptomatic diagnosis (age 16 years) was also included. Clinical and magnetic resonance findings were retrospectively recorded in all patients. All patients were examined to assess clinical evolution, using functional, pyramidal, cerebellar and cognitive scales. This multi-centric study included 16 patients from 14 families. A sex ratio imbalance was noted (male/female = 3/13). The mean age of onset was 31.1 years (range 16-62). Initial symptoms were neurologic (n = 11), psychiatric (n = 2) and ovarian failure (n = 2). Onset of the symptoms was linked to a precipitating factor in 13% of cases that included minor head trauma and delivery. During follow-up (mean: 11.2 years, range 2-22 years) 12.5% of the patients died. Of the 14 survivors, 62% showed a decline in their cognitive functions, and 79% were severely handicapped or bedridden. One case remained asymptomatic. Stress worsened clinical symptoms in 38% of the patients. Magnetic resonance imaging findings consist of constant cerebral atrophy, extensive cystic leucoencephalopathy (81%), corpus callosum (69%) and cerebellar (38%) T2-weighted hyperintensities. All families except one showed mutations in the EIF2B5 gene. The recurrent p.Arg113His-eIF2Bepsilon mutation was found in 79% of the 14 eIF2B-mutated families, mainly at a homozygous state. The family with a mutation in EIF2B2 had the relatively prevalent p.Glu213Gly mutation. eIF2B-related disorder is probably underestimated as an adult-onset inherited leucoencephalopathy. In this late-onset form, presentation ranges from neurologic symptoms to psychiatric manifestations or primary ovarian failure. Cerebral atrophy is constant, whereas the typical vanishing of the white matter can be absent. Functional and/or cognitive prognosis remains severe. Molecular diagnosis is facilitated for these forms by the screening of the two recurrent p.Arg113His-eIF2Bepsilon and p.Glu213Gly-eIF2Bbeta mutations, positive in 86% of cases.
五个真核生物起始因子2B基因(EIF2B1 - 5)之一的突变最初是在儿童期共济失调伴大脑髓鞘形成减少——脑白质消失综合征中被描述的。该综合征的特征为:(i)2至5岁儿童出现小脑和锥体束征;(ii)广泛的空洞性白质脑病;(iii)应激后快速恶化发作。从那时起,已报道了从先天性到成人发病形式的广泛临床谱,从而引出了eIF2B相关疾病的概念。我们的目的是描述成人发病的eIF2B相关疾病(16岁以后)患者的临床和脑磁共振成像特征、基因发现及自然病史。纳入标准基于存在eIF2B突变且发病年龄在16岁以后。还纳入了一名无症状诊断(16岁)的患者。回顾性记录了所有患者的临床和磁共振检查结果。使用功能、锥体束、小脑和认知量表对所有患者进行检查以评估临床进展。这项多中心研究纳入了来自14个家庭的16名患者。注意到了性别比例失衡(男/女 = 3/13)。平均发病年龄为31.1岁(范围16 - 62岁)。初始症状为神经系统症状(n = 11)、精神症状(n = 2)和卵巢功能衰竭(n = 2)。13%的病例症状发作与促发因素有关,包括轻度头部外伤和分娩。在随访期间(平均:11.2年,范围2 - 22年),12.5%的患者死亡。在14名幸存者中,62%出现认知功能下降,79%严重残疾或卧床不起。1例仍无症状。38%的患者应激会使临床症状恶化。磁共振成像结果包括持续性脑萎缩、广泛的囊性白质脑病(81%)、胼胝体(69%)和小脑(38%)T2加权高信号。除一个家庭外,所有家庭均显示EIF2B5基因存在突变。在14个eIF2B突变家庭中的79%发现了复发性p.Arg113His - eIF2Bε突变,主要为纯合状态。EIF2B2基因发生突变的家庭具有相对常见的p.Glu213Gly突变。eIF2B相关疾病作为一种成人发病的遗传性白质脑病可能被低估。在这种晚发型中,表现范围从神经系统症状到精神症状或原发性卵巢功能衰竭。脑萎缩是持续性的,而典型的脑白质消失可能不存在。功能和/或认知预后仍然严重。通过筛查两种复发性p.Arg113His - eIF2Bε和p.Glu213Gly - eIF2Bβ突变有助于对这些类型进行分子诊断,在86%的病例中呈阳性。